Skip to main content

Advertisement

Log in

Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Aim

To evaluate the efficacy of intravitreal injections of ranibizumab in adult-onset foveomacular vitelliform dystrophy (AOFVD).

Methods

Six female patients were misdiagnosed in the office as occult choroidal neovascularization due to AMD, and scheduled for 3-monthly intravitreal injections of ranibizumab. One month after the third injection, all patients underwent further examinations consisting of visual acuity, optical coherence tomography, Indocyanine Green angiography, electrophysiological tests (electroretinogram and electrooculogram), and an exhaustive familial history of macular diseases. Cases were followed-up every 6 weeks since the formal diagnose of AOFVD was evidenced.

Results

The mean BCVA improved from 0.36 ± 0.1 at baseline to 0.56 ± 0.1 (p = 0.038). No significant change was evidence in the SD-OCT thickness analysis. Metamorphopsia disappeared completely in all cases after the first injection. No familial history was evidenced.

Conclusions

Ranibizumab intravitreal injections are effective in the short-term BCVA improvement in patients with AOFVD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Glacet-Bernard A, Soubrane G, Coscas G (1990) Macular vitelliform degeneration in adults: retrospective study of a series of 85 patients. J Fr Ophtalmol 13:407–420

    PubMed  CAS  Google Scholar 

  2. Burgess DB, Olk RJ, Uniat LM (1987) Macular disease resembling adult foveomacular vitelliform dystrophy in older adults. Ophthalmology 94:362–366

    PubMed  CAS  Google Scholar 

  3. Lee JY, Lim J, Chung H, Kim JG, Yoon YH (2009) Spectral domain optical coherence tomography in a patient with adult-onset vitelliform dystrophy treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 40:319–321

    Article  PubMed  Google Scholar 

  4. Montero JA, Ruiz-Moreno JM, De La Vega C (2007) Intravitreal bevacizumab for adult-onset vitelliform dystrophy. Eur J Ophthalmol 17:983–986

    PubMed  CAS  Google Scholar 

  5. Cohen SY, Chretien P, Cochard C, Coscas GJ (1993) Monozygotic twin sisters with adult vitelliform macular dystrophy. Am J Ophthalmol 116:246–247

    PubMed  CAS  Google Scholar 

  6. Benhamou N, Souied EH, Zolf R, Coscas F, Coscas G, Soubrane G (2003) Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography. Am J Ophthalmol 135:362–367

    Article  PubMed  Google Scholar 

  7. Lim JI, Enger C, Fine SL (1994) Foveomacular dystrophy. Am J Ophthalmol 117:1–6

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Gallego-Pinazo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallego-Pinazo, R., Dolz-Marco, R., Pardo-López, D. et al. Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy. Graefes Arch Clin Exp Ophthalmol 249, 455–458 (2011). https://doi.org/10.1007/s00417-010-1536-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-010-1536-1

Keywords

Navigation